Clinical Trials Browser

Phase 2 × OTHER × Glioblastoma × Clear all

NCT07476794 2026-03-17

TEMPO

Phase 2 Recruiting

Glioblastoma

NCT05753007 2026-03-16

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Phase 2 Terminated

2 enrolled 13 charts

Glioblastoma

NCT03475186 2026-03-13

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Phase 2 Completed

75 enrolled 47 charts

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

NCT04044937 2026-03-11

UC-GlioFET

Phase 2 Completed

Brain Neoplasms, Glioblastoma

NCT07462507 2026-03-10

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Phase 2 Not yet recruiting

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT05463848 2026-03-04

Surgical Pembro +/- Olaparib w TMZ for rGBM

Phase 2 Recruiting

Glioblastoma

NCT05607407 2026-03-04

Methimazole in Patients With Progressive Glioblastoma

Phase 2 Recruiting

Glioblastoma, Glioma

NCT05843253 2026-03-04

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Phase 2 Recruiting

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT07439172 2026-02-27

PRC

Phase 2 Not yet recruiting

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT02455557 2026-02-25

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase 2 Active not recruiting

66 enrolled 11 charts

Glioblastoma, Gliosarcoma

NCT06058988 2026-02-23

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

Phase 2 Recruiting

Brain Neoplasms, Glioblastoma, Neoplasm Metastasis, Meningeal Carcinomatosis

NCT04765514 2026-02-13

Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients

Phase 2 Recruiting

Glioblastoma

NCT07263438 2026-02-13

Phenix

Phase 2 Recruiting

Glioblastoma, Recurrence

NCT03405792 2026-02-06

2-THE-TOP

Phase 2 Active not recruiting

40 enrolled 11 charts

Glioblastoma

NCT05653622 2026-02-04

SIB-DOPA

Phase 2 Recruiting

Glioblastoma

NCT05781321 2026-02-03

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

Phase 2 Active not recruiting

Glioblastoma

NCT07301268 2026-02-03

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Phase 2 Suspended

Astrocytoma, Glioblastoma, Gliosarcoma

NCT02394626 2026-02-02

RESURGE

Phase 2 Recruiting

Glioblastoma

NCT05629702 2026-01-30

ARISTOCRAT

Phase 2 Recruiting

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

NCT07364786 2026-01-23

AFGBMBiop

Phase 2 Recruiting

Glioblastoma

NCT02179086 2026-01-14

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase 2 Active not recruiting

Glioblastoma

NCT04623931 2026-01-14

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Phase 2 Recruiting

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT05465954 2026-01-12

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Phase 2 Recruiting

Glioblastoma, Gliosarcoma

NCT05871021 2026-01-09

PRIDE

Phase 2 Recruiting

Glioblastoma

NCT04049669 2026-01-08

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Phase 2 Active not recruiting

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma

NCT04221503 2026-01-08

Niraparib/TTFields in GBM

Phase 2 Active not recruiting

Glioblastoma

NCT03743662 2026-01-07

Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Phase 2 Active not recruiting

Glioblastoma

NCT06558214 2026-01-07

OPTIMUS PRIME

Phase 2 Recruiting

Glioblastoma

NCT02617745 2026-01-02

GLIOPLAK

Phase 2 Completed

CNSClassical hematology

Glioblastoma, Thrombocytopenia

NCT04959500 2026-01-02

Newly Diagnosed Glioblastoma

Phase 2 Active not recruiting

Glioblastoma

NCT05708352 2025-12-24

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

Phase 2 Recruiting

Glioblastoma

NCT07285044 2025-12-22

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Phase 2 Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidMyeloidPlasma cellThoracic

Amyloidosis, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Lymphoma, Mantle-Cell

NCT04691960 2025-12-19

A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging

Phase 2 Active not recruiting

Glioblastoma

NCT02177578 2025-12-18

Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

Phase 2 Active not recruiting

Glioblastoma

NCT05183204 2025-12-18

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Phase 2 Suspended

Glioblastoma

NCT07284628 2025-12-16

ReVoGlio

Phase 2 Not yet recruiting

Glioblastoma

NCT02344355 2025-12-12

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

Phase 2 Active not recruiting

Glioblastoma

NCT04391062 2025-12-05

DOSINDYGO

Phase 2 Completed

Glioblastoma, Neoplasms

NCT03532295 2025-11-21

Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas

Phase 2 Completed

51 enrolled 16 charts

Glioblastoma, Glioma

NCT05052957 2025-11-21

hSTAR GBM

Phase 2 Recruiting

Glioblastoma

NCT03746080 2025-11-14

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Phase 2 Completed

21 enrolled 12 charts

Glioblastoma, Glioma, Gliosarcoma

NCT02977780 2025-11-10

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Phase 2 Recruiting

Glioblastoma

NCT03868943 2025-10-21

JAZZ

Phase 2 Terminated

2 enrolled 5 charts

Glioblastoma, Glioma

NCT06804655 2025-10-02

EViDENCE-BT

Phase 2 Not yet recruiting

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT06439420 2025-10-01

CBT-I in PBT

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Sleep Initiation and Maintenance Disorders, Lymphoma, Meningioma, Oligodendroglioma

NCT07193654 2025-09-26

Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

Phase 2 Recruiting

Glioblastoma, Meningeal Carcinomatosis

NCT05608395 2025-09-25

GlioMET

Phase 2 Completed

Glioblastoma

NCT06649851 2025-09-25

G-CSF After Chemo-radiation in Patients With Glioblastoma

Phase 2 Recruiting

Glioblastoma

NCT06835803 2025-09-18

ELITE-GBM

Phase 2 Recruiting

Glioblastoma

NCT06492486 2025-09-16

GLADIATOR

Phase 2 Not yet recruiting

Glioblastoma